Real-time monitoring of oxygen consumption is beneficial to predict treatment responses and optimize therapeutic protocols for photodynamic therapy (PDT). In this work, we first demonstrate that deformable hollow mesoporous organosilica nanoparticles (HMONs) can be used to load [(Ru(dpp)(3))]Cl-2 for detecting oxygen (denoted as HMON-[(Ru(dpp)(3))]Cl-2). This nanoprobe shows significantly improved biocompatibility and high cellular uptake. In-vitro experiments demonstrate that the HMON-[(Ru(dpp)(3))]Cl-2 can sensitively detect oxygen changes between 1% and 20%. On this basis, photosensitizer chlorin e6 (Ce6) and [(Ru(dpp)(3))]Cl-2 are simultaneously loaded in the HMONs (denoted as HMON-Ce6-[(Ru(dpp)(3))]Cl-2) for real-time oxygen monitoring during photodynamic therapy. The HMON-Ce6-[(Ru(dpp)(3))]Cl-2 can reflects oxygen consumption in solution and cells in photodynamic therapy. Furthermore, the ability of the HMON-Ce6-[(Ru(dpp)(3))]Cl-2 nanosensor to monitor oxygen changes is demonstrated in tumor-bearing nude mice.
基金：
National Key Basic Research Program of the PRC [2014CB744501, 2014CB744504]; National Natural Science Foundation of China [81322020, 81230032, 81530054, 81501538, 81601556]; Natural Science Foundation of Jiangsu Province [BK20160017]
工程技术